Modified UCN2 peptide treatment improves skeletal muscle mass and function in mouse models of obesity‐induced insulin resistance

Abstract Background Type 2 diabetes and obesity are often seen concurrently with skeletal muscle wasting, leading to further derangements in function and metabolism. Muscle wasting remains an unmet need for metabolic disease, and new approaches are warranted. The neuropeptide urocortin 2 (UCN2) and...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Melissa L. Borg, Julie Massart, Thais De Castro Barbosa, Adrià Archilla‐Ortega, Jonathon A.B. Smith, Johanna T. Lanner, Jorge Alsina‐Fernandez, Benjamin Yaden, Alexander E. Culver, Håkan K.R. Karlsson, Joseph T. Brozinick, Juleen R. Zierath
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Wiley 2021-10-01
Ráidu:	Journal of Cachexia, Sarcopenia and Muscle
Fáttát:	Muscle wasting Obesity Diabetes Insulin resistance Exercise Therapy
Liŋkkat:	https://doi.org/10.1002/jcsm.12746
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!